Orange Book product · Brand (NDA)

ATMEKSI

METHOCARBAMOL

Brand (NDA)NDA 219843RX ROSEMONT PHARMS

Jul 30, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Jul 30, 2025
11 mo ago
Today
Patent 12390439 expires
Listed drug product patent expiration.
Oct 09, 2044
in 18 yr 7 mo

Active ingredient

METHOCARBAMOL

Strength

750MG/5ML

Dosage form

SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 219843

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
12390439	Oct 09, 2044	in 18 yr 7 mo	ProductU-4253